[ET Net News Agency, 26 March 2024] BOCI lowered the target price for JD Health (06618)
to HKD43 from HKD65 and maintained the "buy" rating.
The research house said it maintains 2024-2025E topline and GPM estimates unchanged
while its trimmed bottom line forecasts reflect increased opex and decreased interest
income. (RC)